Moonfare’s recent investment strategy opens a door to a key industry nowadays, expected to reach $727bn by 2025 – biotechnology.
The fund manager holds a strong track record of investing in the fastest growing generation of healthcare companies, operating at the intersection of tech and biotech.
To learn more about opportunities to invest in private equity funds, please contact our team or your dedicated relationship manager. Please note that for regulatory reasons, Moonfare is only permitted to share specific investment opportunities with qualified registered users.
$125 million investment, secondary market launch, $1 billion AuM and more – Moonfare 2021 highlights
The financial industry is poised for the largest end-of-year bonus boost since the Great Recession more than ten years ago.
Bordier & Cie, a leading Swiss private bank is pleased to announce that it is the first bank in Switzerland to sign a partnership with Moonfare. Partnership benefits private clients by expanding their access to top tier private equity funds through the Moonfare platform, that offers an easy-to-use experience.